New Cancer Treatment Advances to Phase 2 Trials

TL;DR
Researchers are showing promising progress in treating small cell lung cancer with a new immunotherapy targeting PDL1 and VEGF, demonstrating significant tumor reduction in a Phase 2 trial, which could mark a breakthrough in difficult cancer treatments.
Topics:healthhealth-and-medicine#biontech#cancer-treatment#clinical-trials#health-and-medicine#immunotherapy#lung-cancer
- A promising new treatment for a tough cancer statnews.com
- Breakthrough Cancer Therapy Moves to Phase 2 Trials Georgia State University News
- Groundbreaking Cancer Therapy Advances to Phase 2 Trials BIOENGINEER.ORG
Want the full story? Read the original reporting
Read on statnews.com